Down syndrome: Prenatal risk assessment and diagnosis

American Family Physician

Volumn 62, Issue 4, 2000, Pages 825-832

  Newberger, David S ^a,b  

^a UNIVERSITY AT BUFFALO   (United States)

^b Louis Lazar Family Medicine Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA FETOPROTEIN; CHORIONIC GONADOTROPIN; ESTRIOL;

AMNIOCENTESIS; CHORION VILLUS SAMPLING; DOWN SYNDROME; ECHOGRAPHY; GENETIC COUNSELING; MATERNAL AGE; MATERNAL SERUM; MENTAL DEFICIENCY; PRACTICE GUIDELINE; PRENATAL DIAGNOSIS; REVIEW; RISK FACTOR; SCREENING TEST; SECOND TRIMESTER PREGNANCY; TRISOMY 21;

ALGORITHMS; ALPHA-FETOPROTEINS; AMNIOCENTESIS; BIOLOGICAL MARKERS; CHORIONIC GONADOTROPIN; CHORIONIC VILLI SAMPLING; DECISION TREES; DOWN SYNDROME; ESTRIOL; FEMALE; GENETIC COUNSELING; GENETIC SCREENING; GESTATIONAL AGE; HUMANS; INFORMATION SERVICES; INTERNET; MATERNAL AGE; PARENTS; PREGNANCY; PREGNANCY, HIGH-RISK; PRENATAL DIAGNOSIS; RISK ASSESSMENT; RISK FACTORS; SENSITIVITY AND SPECIFICITY; ULTRASONOGRAPHY, PRENATAL;

EID: 0034663445     PISSN: 0002838X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (29)

1. Down syndrome (Trisomy 21)
2. Down syndrome prevalence at birth - United States, 1983-1990 MMWR
3. Down syndrome and other autosomal trisomies
4. Primary care of infants and young children with Down syndrome
5. Atlantoaxial instability in Down syndrome: Subject review
6. Rates of chromosome abnormalities at different maternal ages
7. Estimating a woman's risk of having a pregnancy associated with Down's syndrome using her age and serum alpha-fetoprotein level
8. An association between low maternal serum alpha-fetoprotein and fetal chromosome abnormalities
9. Contemporary approaches to prenatal diagnosis
10. Maternal serum screening for Down's syndrome in early pregnancy
11. Maternal serum screening for Down syndrome: Clinical aspects
12. Maternal serum screening for Down syndrome in the United States: A 1995 survey
13. Prenatal screening for Down's syndrome with use of maternal serum markers
14. Reducing the need for amniocentesis in women 35 years of age or older with serum markers for screening
15. Down syndrome and neural tube defect screening: The value of using gestational age by ultrasonography
16. The use of second-trimester genetic sonogram in guiding clinical management of patients at increased risk for fetal trisomy 21
17. Screening for the aneuploid fetus
18. Antenatal screening for aneuploidy
19. Prenatal detection of aneuploidy by directly labeled multicolored probes and interphase fluorescence in situ hybridization
20. Counseling prior to prenatal testing
21. Women's experiences of prenatal screening and diagnosis
22. Age-specific detection and false-positive rates: An aid to counseling in Down syndrome risk screening
23. Responding to parental concerns after a prenatal diagnosis of trisomy 21